Best of the AASLD

Reviews in Gastroenterological Disorders

Volumn 2, Issue 1, 2002, Pages 34-40

  Keeffe, Emmet B ^a   Davis, Gary L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALCOHOL; ALLOPURINOL; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CYCLOSPORIN; DEFEROXAMINE; INTERFERON; LAMIVUDINE; METHOTREXATE; PENTOXIFYLLINE; PREDNISONE; RETINOL; RIBAVIRIN; SELENIUM; VIRUS RNA;

ARTIFICIAL EMBOLISM; BILE DUCT CARCINOMA; CANCER RISK; CONFERENCE PAPER; CONTROLLED STUDY; FATTY LIVER; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TOXICITY; LIVER TRANSPLANTATION; MEDICAL SOCIETY; NONHUMAN; PORTAL HYPERTENSION; PRIMARY SCLEROSING CHOLANGITIS; VIRUS HEPATITIS; BILIARY CIRRHOSIS; DISEASE COURSE; DRUG EFFECT; HEPATITIS; LIVER; LIVER TUMOR; PATHOLOGY; SCLEROSING CHOLANGITIS;

CARCINOMA, HEPATOCELLULAR; CHOLANGITIS, SCLEROSING; DISEASE PROGRESSION; HEPATITIS; HEPATITIS, VIRAL, HUMAN; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES; LIVER NEOPLASMS; LIVER TRANSPLANTATION; METHOTREXATE;

EID: 0036050395     PISSN: 1533001X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. The etiology of primary biliary cirrhosis: Connecting xenobiotics to anti-mitochondrial antibodies by ab initio quantum chemistry
2. UDP-glucuronosyltransferase UGT1A7 gene polymorphisms discriminate between primary sclerosing cholangitis (PSC) associated ulcerative colitis and ulcerative colitis
3. The role of liver biopsy in the diagnosis of primary biliary cirrhosis
4. Cholangiocarcinoma in primary sclerosing cholangitis is associated with long-standing inflammatory bowel disease. A long-term follow-up of 394 primary sclerosing cholangitis patients
5. Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: Are serial liver biopsies justified?
6. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis: A randomized trial
7. Does nonalcoholic steatohepatitis (NASH) progress to cryptogenic cirrhosis (CC) and hepatocellular carcinoma (HCC): A case controlled study
8. Adult living donor liver transplantation (LDLT) in the US: Results of the survey from the NIH LDLT meeting
9. Survival after orthotopic liver transplantation (OLT) among patients with hepatic iron overload: Interim results from the National Hemochromatosis Transplant Registry (NHTR)
10. Hepatocyte transplantation (HTX) in children with liver failure
11. Clinical implications of hepatic steatosis inpatients with chronic hepatitis C
12. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and serial liver biopsies
13. Predictive variables of HCV-related disease progression: Negative effect of overweight
14. Early prediction of response to 40 KDA PEG-interferon alfa-2a plus ribavirin in patients with chronic hepatitis C
15. Comparison of three commercially available assays to measure HCV-RNA: Roche Amplicor, Chiron bDNA and NGI SuperQuant
16. Changes in liver histology after 4 years of lamivudine therapy in chronic hepatitis B
17. The effect of longer duration of harbouring lamidivudine-resistant hepatitis B virus (YMDD mutants) on liver histology during 3 years lamivudine therapy in Chinese patients
18. The incidence and progression of esophageal varices in cirrhosis
19. Comparison of clinical and pathologic features of hepatocellular carcinoma in screened and non-screened subjects with cirrhosis
20. Chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of pooled data
21. Transarterial chemoembolization in patients with unresectable hepatocellular carcinoma: A meta-analysis of randomized controlled trials